Advanced search
Publication Cover
Journal of Medical Economics Volume 17, 2014 - Issue 6
Submit an article Journal homepage
879
Views
9
CrossRef citations to date
0
Altmetric
Ophthalmology: Original article

A United Kingdom-based economic evaluation of ranibizumab for patients with retinal vein occlusion (RVO)

Matthew TaylorYork Health Economics Consortium Ltd, University of York YorkUKCorrespondence[email protected]
,
Elçin SerbetciYork Health Economics Consortium Ltd, University of York YorkUK
,
Alberto FerreiraNovartis Pharma AG BaselSwitzerland
,
Kerry GairyAlcon Eye Care UK Ltd SurreyUK
,
Lily LewisYork Health Economics Consortium Ltd, University of York YorkUK
,
Julie BlouinNovartis Pharmaceuticals Canada Inc. Dorval, QuebecCanada
&
Paul MitchellCentre for Vision Research (Westmead Millennium Institute), University of Sydney Sydney, NSWAustralia
 show all
Pages 423-434 | Accepted 25 Mar 2014, Published online: 22 Apr 2014

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Inês Ribeiro, Francisco Batel Marques, Diogo Mendes & Carlos Alves. (2020) A Systematic Review of Economic Studies Evaluating Ophthalmic Drugs: An Analysis of the Health-state Utilities. Ophthalmic Epidemiology 27:5, pages 325-338.
Read now

Articles from other publishers (8)

Nikolaos T. Voutsas, Eleni Papageorgiou, Alexandra Tantou, Vassilis A. Dimitriou, Evangelia E. Tsironi & Maria Kotoula. (2022) Quality-adjusted life years in macular oedema due to age-related macular degeneration, diabetes and central retinal vein occlusion: the impact of anti-VEGF agents in a tertiary centre in Greece. International Ophthalmology 42:9, pages 2673-2684.
Crossref
Weiyi Ni, Jia Liu, Yawen Jiang & Jing Wu. (2021) Cost-effectiveness analysis of ranibizumab for retinal vein occlusion patients in China from the societal perspective. BMC Ophthalmology 21:1.
Crossref
Philip Hykin, A Toby Prevost, Sobha Sivaprasad, Joana C Vasconcelos, Caroline Murphy, Joanna Kelly, Jayashree Ramu, Abualbishr Alshreef, Laura Flight, Rebekah Pennington, Barry Hounsome, Ellen Lever, Andrew Metry, Edith Poku, Yit Yang, Simon P Harding, Andrew Lotery, Usha Chakravarthy & John Brazier. (2021) Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT. Health Technology Assessment 25:38, pages 1-196.
Crossref
Ian L. McAllister, Lynne A. Smithies, Fred K. Chen, David A. Mackey & Paul G. Sanfilippo. (2018) Two-Year Efficacy of Ranibizumab Plus Laser-Induced Chorioretinal Anastomosis vs Ranibizumab Monotherapy for Central Retinal Vein Occlusion. JAMA Ophthalmology 136:12, pages 1391.
Crossref
Jun Ho Yoo, Jaemoon Ahn, Jaeryung Oh, Jaehyung Cha & Seong-Woo Kim. (2017) Risk factors of recurrence of macular oedema associated with branch retinal vein occlusion after intravitreal bevacizumab injection. British Journal of Ophthalmology 101:10, pages 1334-1339.
Crossref
Steven E. Bradshaw, Smeet Gala, Merena Nanavaty, Anshul Shah, Mkaya Mwamburi & Panos Kefalas. (2016) Systematic literature review of treatments for management of complications of ischemic central retinal vein occlusion. BMC Ophthalmology 16:1.
Crossref
Lola Adedokun & Colin Burke. (2016) Cost-Effectiveness of Ranibizumab Versus Aflibercept for Macular Edema Secondary to Branch Retinal Vein Occlusion: A UK Healthcare Perspective. Advances in Therapy 33:1, pages 116-128.
Crossref
Ahmet Ozkok, Omar A. Saleh, Douglas K. Sigford, James W. Heroman & Shlomit Schaal. (2015) THE OMAR STUDY. Retina 35:7, pages 1393-1400.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.